Zevra Therapeutics, Inc
Filings
Newest firstThe annual , the quarterly and the filed between them when something material happens.
- Nov 310-QQuarterly report
- Nov 38-KResults of operations2.029.01
- Aug 510-QQuarterly report
- Aug 58-KResults of operations2.029.01
- Jul 3113GPassive stake of 5% or more (13G), filed by Vanguard Capital Management
- Jun 58-KShareholder vote5.079.01
- May 610-QQuarterly report
- May 68-KResults of operations2.029.01
- Mar 168-KMaterial agreement and Regulation FD disclosure1.011.027.019.01
- Mar 910-KAnnual report
- Mar 98-KResults of operations and officer or director change2.025.029.01
- Dec 17, 20258-KOfficer or director change5.029.01
- Dec 2, 20258-KOfficer or director change and Regulation FD disclosure5.027.019.01
- Nov 20, 20258-KOfficer or director change and Regulation FD disclosure5.027.019.01
- Nov 5, 202510-QQuarterly report
- Nov 5, 20258-KResults of operations2.029.01
- Aug 12, 202510-QQuarterly report
- Aug 12, 20258-KResults of operations2.029.01
- May 29, 20258-KShareholder vote5.07
- May 13, 202510-QQuarterly report
- May 13, 20258-KResults of operations2.029.01
- Apr 7, 20258-KAcquisition or sale of assets completed and results of operations2.012.028.019.01
- Mar 12, 202510-KAnnual report
- Mar 11, 20258-KResults of operations2.029.01
- Feb 27, 20258-KMaterial agreement and Regulation FD disclosure1.017.019.01
- Dec 6, 20248-KOfficer or director change and Regulation FD disclosure5.027.019.01
- Nov 21, 20248-KRegulation FD disclosure and other events7.018.019.01
- Nov 13, 202410-QQuarterly report
- Nov 12, 20248-KResults of operations2.029.01